These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11180114)

  • 21. Action of intracellular IL-1Ra (Type 1) is independent of the IL-1 intracellular signalling pathway.
    Evans I; Dower SK; Francis SE; Crossman DC; Wilson HL
    Cytokine; 2006 Mar; 33(5):274-80. PubMed ID: 16564702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression.
    Carl VS; Gautam JK; Comeau LD; Smith MF
    J Leukoc Biol; 2004 Sep; 76(3):735-42. PubMed ID: 15218058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and secretion of interleukin-1 alpha and interleukin-1 receptor antagonist during differentiation of cultured keratinocytes.
    Corradi A; Franzi AT; Rubartelli A
    Exp Cell Res; 1995 Apr; 217(2):355-62. PubMed ID: 7698236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.
    Ulich TR; Guo K; Yin S; del Castillo J; Yi ES; Thompson RC; Eisenberg SP
    Am J Pathol; 1992 Jul; 141(1):61-8. PubMed ID: 1385928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracellular release of the type I intracellular IL-1 receptor antagonist from human airway epithelial cells: differential effects of IL-4, IL-13, IFN-gamma, and corticosteroids.
    Levine SJ; Wu T; Shelhamer JH
    J Immunol; 1997 Jun; 158(12):5949-57. PubMed ID: 9190949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovarian interleukin-1 receptor antagonist in rats: gene expression, cellular localization, cyclic variation, and hormonal regulation of a potential determinant of interleukin-1 action.
    Kol S; Donesky BW; Ruutiainen-Altman K; Ben-Shlomo I; Irahara M; Ando M; Rohan RM; Adashi EY
    Biol Reprod; 1999 Jul; 61(1):274-82. PubMed ID: 10377059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human intracellular interleukin 1 receptor antagonist promoter appropriately regulates gene expression in keratinocytes and gastrointestinal epithelial cells in vivo.
    Gabay C; Smith MF; Arend WP
    Cytokine; 1999 Aug; 11(8):561-70. PubMed ID: 10433802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of a biologically active recombinant mouse IL-1 receptor antagonist and its use in vivo to modulate aspects of the acute phase response.
    Grehan S; Uhlar CM; Sim RB; Herbert J; Whitehead AS
    J Immunol; 1997 Jul; 159(1):369-78. PubMed ID: 9200475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD14 is an acute-phase protein.
    Bas S; Gauthier BR; Spenato U; Stingelin S; Gabay C
    J Immunol; 2004 Apr; 172(7):4470-9. PubMed ID: 15034063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Articular inflammation is controlled by myeloid cell-derived interleukin 1 receptor antagonist during the acute phase of arthritis in mice.
    Lamacchia C; Rodriguez E; Palmer G; Vigne S; Martin P; Talabot-Ayer D; Seemayer CA; Gabay C
    Ann Rheum Dis; 2012 Feb; 71(2):281-7. PubMed ID: 22072017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The production of IL-1 receptor antagonist in IFN-beta-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1.
    Molnarfi N; Hyka-Nouspikel N; Gruaz L; Dayer JM; Burger D
    J Immunol; 2005 Mar; 174(5):2974-80. PubMed ID: 15728510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional regulation of intracellular IL-1 receptor antagonist gene by IL-1 alpha in primary mouse keratinocytes.
    La E; Fischer SM
    J Immunol; 2001 May; 166(10):6149-55. PubMed ID: 11342635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia.
    Calkins CM; Bensard DD; Shames BD; Pulido EJ; Abraham E; Fernandez N; Meng X; Dinarello CA; McIntyre RC
    J Endotoxin Res; 2002; 8(1):59-67. PubMed ID: 11981446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1ra.
    Josephs MD; Solorzano CC; Taylor M; Rosenberg JJ; Topping D; Abouhamze A; Mackay SL; Hirsch E; Hirsh D; Labow M; Moldawer LL
    Am J Physiol Regul Integr Comp Physiol; 2000 Apr; 278(4):R824-30. PubMed ID: 10749768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential contribution of IL-1Ra isoforms to allele-specific IL-1Ra mRNA accumulation.
    Redlitz KH; Yamshchikov VF; Cominelli F
    J Interferon Cytokine Res; 2004 Apr; 24(4):253-60. PubMed ID: 15144571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome.
    Banda NK; Guthridge C; Sheppard D; Cairns KS; Muggli M; Bech-Otschir D; Dubiel W; Arend WP
    J Immunol; 2005 Mar; 174(6):3608-16. PubMed ID: 15749898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils.
    Jenkins JK; Malyak M; Arend WP
    Lymphokine Cytokine Res; 1994 Feb; 13(1):47-54. PubMed ID: 8186324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential synthesis of two interleukin-1 receptor antagonist variants and interleukin-8 by peripheral blood neutrophils.
    Schröder AK; von der Ohe M; Fleischer D; Rink L; Uciechowski P
    Cytokine; 2005 Dec; 32(5):246-53. PubMed ID: 16343927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation.
    Wilson HL; Francis SE; Dower SK; Crossman DC
    J Immunol; 2004 Jul; 173(2):1202-8. PubMed ID: 15240711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular interleukin-1 receptor antagonist type 1 antagonizes the stimulatory effect of interleukin-1 alpha precursor on cell motility.
    Merhi-Soussi F; Berti M; Wehrle-Haller B; Gabay C
    Cytokine; 2005 Nov; 32(3-4):163-70. PubMed ID: 16246569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.